BTIG Maintains Buy on Bionano Genomics, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Mark Massaro maintains a Buy rating on Bionano Genomics (NASDAQ:BNGO) and raises the price target from $2 to $10.
August 10, 2023 | 7:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bionano Genomics' price target has been raised from $2 to $10 by BTIG analyst Mark Massaro, who maintains a Buy rating on the stock.
The price target increase for Bionano Genomics by a respected analyst is a positive signal for the stock. It suggests that the analyst sees significant upside potential in the stock, which could drive investor interest and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100